101
Participants
Start Date
November 30, 2007
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
MP-470 + topotecan
Topotecan 1.5 mg/m2 IV infusion over 30 minutes on Days 1-5
MP-470 + docetaxel
Docetaxel 75 mg/m2 IV infusion over 1 hour on Day 1
MP-470 + erlotinib
150 mg PO once daily at least 1 hour before or 2 hours after eating
MP-470 + paclitaxel/carboplatin
Paclitaxel 200 mg/m2 IV infusion over 3 hours followed by carboplatin IV infusion over 1 hour to a target AUC of 6 mg∙min/mL on Day 1
MP-470 + carboplatin/etoposide
Carboplatin IV infusion over 1 hour to target AUC of 5 mg min/mL on Day 1 followed by etoposide 100 mg/m2 IV infusion over 2 hours on Days 1-3
Audie Murphy Veterans Memorial Hospital (VA), San Antonio
CTRC at the UT Health Science Center at San Antonio, San Antonio
South Texas Accelerated Research Therapy (START), San Antonio
Premiere Oncology, Scottsdale
Premiere Oncology, Santa Monica
Lead Sponsor
Astex Pharmaceuticals, Inc.
INDUSTRY